Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
View Older Stories
-
Vade joins Hornetsecurity Group, creating a European cybersecurity leader
-
Seadrill Announces Fourth Quarter and Full Year 2023 Results
-
Seadrill Ltd. (SDRL) Provides Commercial Updates on West Vela, West Capella, and West Auriga
-
Seadrill Provides Commercial Updates on West Vela, West Capella, and West Auriga
-
Seadrill Ltd. (SDRL) Announces Contracts for West Auriga and West Polaris in Brazil
-
Seadrill Announces Contracts for West Auriga and West Polaris in Brazil
-
Singapore Tourism Board Unveils How A "Best Night Ever" is Made in Singapore Through Latest Campaign
-
Seadrill Ltd. (SDRL) Reports Q3, Announces Additional $250M Share Buyback
-
Seadrill Announces Third Quarter 2023 Results and Additional $250 Million Share Repurchase Authorization
-
SentinelOne Celebrates Strength of Global Partner Ecosystem
-
Mercedes-Benz 540K Named Best of Show at the 72nd Pebble Beach Concours d'Elegance
-
Seadrill Ltd. (SDRL) Reports Q2, Announces $250M Share Buyback
-
Seadrill Announces Second Quarter 2023 Results and $250 Million Share Repurchase Authorization
-
Flash Therapeutics Appoints Jérôme Bédier as President to Accelerate its Biopharmaceutical CDMO Business Development
-
Small funds eyeing big gains pile on Venezuela debt
-
PHERECYDES Strengthens its Corporate Links with ERYTECH to Prepare the Strategic Combination
-
ERYTECH Provides Update on the Announced Combination with PHERECYDES
-
Aflibercept 8 mg and EYLEA® (aflibercept) Injection Presentations at ARVO Provide New Insights into the Treatment of Serious Retinal Diseases
-
Aflibercept 8 mg and EYLEA® (aflibercept) Injection Presentations at ARVO Provide New Insights into the Treatment of Serious Retinal Diseases
-
ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies
-
Vade Celebrates a Year of Achievements
-
Improved comfort for E-Bike Commuters In Fountain Valley Announced By E-Lux
-
Improved Comfort for E-Bike Commuters in Fountain Valley Announced by E-Lux
-
NEUWAY Pharma Appoints Healthcare Sector Veteran Dr Jacques Mallet to its Advisory Board
-
Aurigami Minimizes Risks in Proactive Precaution with Risk DAO
-
Aquadrill Announces Extension of Charter Hire Agreement for the Auriga
-
Diamond Offshore Reports Second Quarter 2022 Results and Announces $610 Million in New Contract Awards
-
Form D Auriga Stream Ventures
-
Aurigami Collects $12M Warchest to Grow Aurora-Based Lending Protocol
-
CAPELLA HOTELS AND RESORTS EXPANDS INTO JAPAN WITH CAPELLA KYOTO
-
MOKWHEEL Unveils Basalt, An Epic Power Backup Ebike with the Most Innovative Features
-
Vade Lands $30 Million in New Funding Round
-
Diamond Offshore Announces First Quarter 2022 Results
-
Bonitasoft Exceeds 2021 Forecast for Revenue and Retention
-
Fortino Capital Invests in Bonitasoft to Accelerate Growth and Consolidate the Company’s Leadership Position in Digital Process Automation
-
Abra Launches Crypto Perx (CPRX) Token With Airdrop to Customers
-
Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector
-
Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector
-
Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector
-
Abra Launches Token-Based Rewards Program for Customers Powered by Crypto Perx (CPRX)
-
Aquadrill Announces Charter Hire Agreement for the Auriga
-
Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients
-
Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients
-
AIC Offers AMD EPYC™ 7003 Processor-Based Server Boards and HCI Server Systems
-
Trase: The Indonesia's pulp sector has achieved an 85% reduction of deforestation since 2011, but remains dependent on carbon-intensive peatland plantations
-
DCH Auriga selected as the exclusive distributor of the Sinovac COVID-19 vaccine in Hong Kong
-
ACI Worldwide and Auriga Partner to Launch Next-Generation ATM Acquiring and Self-Service Banking Platform
-
DCH Auriga selected as the logistics partner to distribute the Fosun Pharma BioNTech COVID-19 vaccine in Hong Kong
-
WiLAN, a Quarterhill Company, Announces New Intel License Agreement

